Works matching AU Iqbal, Nayyar


Results: 75
    1
    2
    3
    4
    5

    Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 549, doi. 10.1111/dom.14248
    By:
    • Phillip, Moshe;
    • Mathieu, Chantal;
    • Lind, Marcus;
    • Araki, Eiichi;
    • Bartolo, Paolo;
    • Bergenstal, Richard;
    • Heller, Simon;
    • Hansen, Lars;
    • Scheerer, Markus Florian;
    • Thoren, Fredrik;
    • Arya, Niki;
    • Xu, John;
    • Iqbal, Nayyar;
    • Dandona, Paresh
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).

    Published in:
    2019
    By:
    • Bethel, M. Angelyn;
    • Patel, Rishi A.;
    • Thompson, Vivian P.;
    • Merrill, Peter;
    • Reed, Shelby D.;
    • Li, Yanhong;
    • Ahmadi, Sara;
    • Katona, Brian G.;
    • Gustavson, Stephanie M.;
    • Ohman, Peter;
    • Iqbal, Nayyar;
    • Gagel, Robert F.;
    • Hernandez, Adrian F.;
    • Buse, John B.;
    • Holman, Rury R.;
    • EXSCEL Study Group
    Publication type:
    journal article
    19

    Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.

    Published in:
    2017
    By:
    • Mosenzon, Ofri;
    • Leibowitz, Gil;
    • Bhatt, Deepak L.;
    • Cahn, Avivit;
    • Hirshberg, Boaz;
    • Wei, Cheryl;
    • KyungAh Im;
    • Rozenberg, Aliza;
    • Yanuv, Ilan;
    • Stahre, Christina;
    • Ray, Kausik K.;
    • Iqbal, Nayyar;
    • Braunwald, Eugene;
    • Scirica, Benjamin M.;
    • Raz, Itamar;
    • Im, KyungAh
    Publication type:
    journal article
    20
    21
    22
    23
    24
    25

    Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.

    Published in:
    2018
    By:
    • Mentz, Robert J.;
    • Bethel, M. Angelyn;
    • Merrill, Peter;
    • Lokhnygina, Yuliya;
    • Buse, John B.;
    • Chan, Juliana C.;
    • Felício, João S.;
    • Goodman, Shaun G.;
    • Choi, Jasmine;
    • Gustavson, Stephanie M.;
    • Iqbal, Nayyar;
    • Lopes, Renato D.;
    • Maggioni, Aldo P.;
    • Öhman, Peter;
    • Pagidipati, Neha J.;
    • Poulter, Neil R.;
    • Ramachandran, Ambady;
    • Reicher, Barry;
    • Holman, Rury R.;
    • Hernandez, Adrian F.
    Publication type:
    journal article
    26
    27
    28
    29
    30
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50